|
|
|
Contact Us||
About Us
|
|
|
 |
|
|
|
|
|

Vol. 1(7), August 2012
Other
viewing option
Abstract
•
Full
text
•Reprint
(PDF) (217 KB)
Search Pubmed for articles by:
Prashant K
Amit KJ
Other links:
PubMed Citation
Related articles in PubMed
|
|
Global Advanced
Research Journal of Educational Research and Reviews (GARJERR)
ISSN: 2315-5132
August 2012 Vol. 1(7), pp. 124-128
Copyright © 2012 Global Advanced
Research Journals
Full Length
Research Paper
|
An
innovative approach to prolong gastric retention:-
“Floating
microspheres of cimetidine hydrochloride”
Prashant K1* and Amit K J2
1Prashant Khemariya Sr. Research Scientist Formulation.
2Department of Pharmacy Dr.H.S.Gour
University Sagar (M.P)
*Corresponding author Email:
dr.p.khemariya@gmail.com
|
|
Abstract |
|
The purpose of this research work was to developed
and optimize a controlled-release multiunit floating
system of a freely water soluble drugs such as (CHCL).
Cimetidine
is a histamine H2-receptor antagonist
that inhibits the production of acid in the stomach.
It is largely used in the treatment of heartburn and
peptic ulcers
Oral delivery of the water soluble drug is so far
the most preferable and ease route of drug delivery
due to the ease of administration, patient
compliance and flexibility in the formulations, but
immediate release to site-specific delivery, oral
dosage form has really progressed as compaired to
novel dosage forms. Various attempts have been made
to develop gastro-retentive delivery systems. For
example floating, swelling, mucoadhesive, and
high-density system. These systems have more
flexibility in dosage design than conventional
dosage form Cimetidine-HCL lipid
microspheres were prepared by the melt granulation
technique and evaluated for in vitro floating and
drug release. Ethyl cellulose, methylcellulose, and
hydroxypropyl methylcellulose were evaluated as
release rate modifiers.
Keywords:
Floating Microspheres, H2 Receptor,
Tagamet HB or Tagamet HB200
|
| |
|
|
|